Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2024-08-05 AGM Information
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Submission of Proceedings of 31st Annual General Meeting.
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 31st Annual General Meeting (AGM) held on Monday August 05, 2024' and details the conduct of the AGM, including attendance, agenda items, voting procedures, and resolutions passed. It includes information about directors present, voting results process, and responses to shareholder queries. The document is a detailed record of the AGM proceedings rather than the full Annual Report or financial statements. It is not a brief announcement or a notice of voting results but a comprehensive summary of the meeting itself. Therefore, it fits the category of AGM Information (AGM-R). The document length (8077 characters) supports it being a full proceedings report rather than a short announcement or certification.
2024-08-05 English
Submission of newspaper publication of extract of unaudited financial results for the quarter ended 30th June 2024.
Regulatory Filings
2024-07-29 English
Submission of Unaudited Financial Results for the quarter ended 30th June, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015.
Regulatory Filings
2024-07-27 English
This is to inform that Board of Directors of the Company in its meeting held on 27th July, 2024 at the corporate office of the company i.e., 8-2-351/w/3/4, Road Number 3, Banjara Hills, ....
Regulatory Filings
2024-07-27 English
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 ,inter alia, to consider and approve the unaudited standalone ....
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to the stock exchange (BSE Limited) informing about an upcoming Board Meeting scheduled for 27th July 2024. The purpose of the meeting is to consider and approve the unaudited standalone financial results for the quarter ended 30th June 2024 along with the Limited Review Report of the Auditors. The document also mentions the closure of the trading window for insiders as per SEBI regulations. The document does not contain the financial results themselves but is an announcement of the meeting where such results will be approved. The document length is short (2138 characters) and it serves as an intimation or notice rather than the actual financial report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and not an Interim/Quarterly Report (IR) or Earnings Release (ER).
2024-07-20 English
Submission of Newspaper publication of notice of 31st Annual General Meeting of the Company.
Regulatory Filings
2024-07-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.